-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Maintains Neutral on Bicycle Therapeutics, Lowers Price Target to $14

Benzinga·05/02/2025 16:01:39
Listen to the news
B. Riley Securities analyst Kalpit Patel maintains Bicycle Therapeutics (NASDAQ:BCYC) with a Neutral and lowers the price target from $17 to $14.